The diet pill market in Europe is expected to reach a value of US $ 868 million by 2031, Finds Fact.MR


According to a new report released by Fact.MR, a provider of market research and competitive intelligence, the European diet pills market is valued at US $ 654 million in 2020 and is expected to grow at a CAGR of around 2, 6% over the forecast period. (2021-2031).

Factors driving the demand for diet pills in Europe include the increased incidence of type 2 diabetes, high cholesterol and high blood pressure. Ongoing clinical trials for new drugs will support the growth of the market over the next few years. In addition, the growing health awareness is also driving the evolution of the market.

Currently, obesity is considered to be a serious health problem, which leads to various other health problems. Diet pills are drugs used to slim down by losing weight with exercise and proper diet. With the growing trend of fitness among young people, the demand for these weight management products is increasing. These drugs act as an additional measure for weight reduction other than the routine exercise regimen and eating habits.

Request a sample report for complete information on

Key points of the market research
  • Glucomannan is expected to contribute over 41% of market revenue by 2031.
  • Among all drug types, demand for herbal supplements is expected to increase at a CAGR of 3% through 2031.
  • Appetite control pills dominate the market among the mechanisms and are expected to reach a valuation of US $ 595 million by 2031.
  • The UK has the highest share of the European diet pill market, while Germany is the next leading country, with these markets expected to grow at 3.6% and 3% CAGR, respectively.

“The increasing prevalence of obesity, an unhealthy lifestyle and a growing awareness of preventive health are factors that have changed the focus of the pharmaceutical industry towards the development of diet pills,” says an analyst at Fact.MR.

A growing number of manufacturers of innovative weight management products

Innovation has played a constant role in the development of diet pills, which creates business opportunities for manufacturers. The development of new products with more health benefits encourages consumers to try new nutritional supplements. Key players are offering calorie restriction diet pills to overcome weight-related risk factors such as diabetes and hypertension.

The increasing prevalence of obesity has prompted manufacturers to innovate more effective diet pill supplements. The expansion of technology platforms and the intensification of research into innovative weight management products are expected to lead to increased market growth.

Request a methodology and get an overview of our expertise

Key Takeaways for Europe Diet Pills Market Research Report:

  • The demand for prescription weight loss pills will continue to increase in the UK. Fact MR predicts that overall sales of diet pills in the country will exceed US $ 193 million by 2031.
  • Sales of diet pills in Germany will increase at 3% CAGR due to growing concerns about health and wellness.
  • By drug class, the glucomannan segment represented more than 39.5% of the European market in 2020.
  • By drug type, herbal dietary supplement sales totaled US $ 444.3 million in 2020 due to increased consumer demand for biologics.

Growth drivers:

  • Increasing spending on dietary supplements and nutrition is boosting demand for diet pills for appetite control.
  • The expansion of diet pills distribution channels will strengthen sales opportunities in Europe.
  • The increasing adoption of drugs for weight loss and obesity control will accelerate the demand for diet pills in Europe.
  • The increased availability on e-commerce platforms will encourage sales of diet pills in Europe.

Get more info-https: // 611- 6-mn-by-2031-fact-mr /

Key restrictions:

  • The high cost of drug development hampers the demand for diet pills.
  • Strict regulations imposed by the research and development of obesity-related drugs will restrain the growth of the market.
  • The adoption of off-label drugs limits the penetration of real drugs, which restricts the growth of the market.

Explore Fact.MR’s healthcare coverage

Genetic Testing Services Market – The future expansion of genetic testing services is highly dependent on advances in information technology. Throughout the projected period, North America is expected to dominate the global genetic testing services market. The increased demand for genetic testing to determine ancestry, along with an increased demand for in vitro fertilization (IVF) and preimplantation testing, are some of the main reasons for the increase in market share. The North American genetic testing market is projected to account for more than two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – During the forecast period, the global rheumatoid arthritis treatment market is expected to increase moderately. During the projected period, the allogeneic mesenchymal stem cell segment is expected to dominate the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals probably account for a significant share of the global rheumatoid arthritis stem cell therapy market.

Serologic Transplantation Diagnostics Market – Serological diagnosis of transplantation, which is an essential component of successful and efficient organ transplantation, has developed rapidly in recent years. The growth of important distribution channels, such as hospitals and organ transplant centers, to name a few, has driven demand over the past five years, from 2016 to 2020, attracting more stakeholders in the company. Sales of serologic transplant diagnostic equipment are driven by an increase in the incidence of severe lung, liver and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. We have offices in the United States and Dublin, while our global headquarters are in Dubai. While our experienced consultants use the latest technology to extract hard-to-find information, we believe our USP is the trust clients have in our expertise. Covering a wide spectrum – from automotive and industry 4.0 to healthcare and retail, our coverage is extensive, but we make sure that even the most specialized categories are analyzed. Contact us with your goals, and we will be a competent research partner.

US Sales Office:
11140 Rockville Pike
Office 400
Rockville, Maryland 20852
United States
Phone. : +1 (628) 251-1583

The head office:
Unit No .: AU-01-H Gold Tower (AU),
Plot number: JLT-PH1-I3A,
Jumeirah Lakes Tours,
Dubai, United Arab Emirates
Email: [email protected]
Visit our website:
Research overview:
Press release:


Leave a Reply

Your email address will not be published.